Research recommendation(s) from an individual piece of guidance

Research recommendations coming out of this guidance

• Cognitive behavioural therapy for people with atrial fibrillation:- What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) compared with usual care for people with newly diagnosed atrial fibrillation?
• Rate control drug treatment for people aged 75 and over with atrial fibrillation:- What is the comparative effectiveness of the 3 main drug classes used for rate control (beta-blockers, calcium-channel blockers and digoxin) in people aged 75 and over with atrial fibrillation in controlling symptoms, improving quality of life and reducing morbidity and mortality?
• Case volume as an indicator of quality for people offered left atrial catheter ablation:- What is the effect of case volume on complications and outcomes after left atrial catheter ablation?
• Non-vitamin K antagonist oral anticoagulants:- Do people with atrial fibrillation whose anticoagulant control is poor, or is predicted to be poor, with warfarin benefit from changing to one of the non-vitamin K antagonist (non-VKA) oral anticoagulants?
• Stroke risk assessment:- Can routine data from UK primary care databases clarify stroke risk in people with atrial fibrillation according to baseline risk factors and treatment?